Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655590 · ClinicalTrials.gov registry record · Phase 4
Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm Function
A Phase 4 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT00655590 is a Phase 4 study that has completed, run by Bayer. The registered enrollment target is 200 participants.
The verdict
NCT00655590, a Phase 4 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
Assess the effect of daily treatment of vardenafil 20mg or sildenafil 100mg and placebo on sperm function
Interventions
- DRUG Placebo
- DRUG Sildenafil
- DRUG Levitra (Vardenafil, BAY38-9456)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2005-01 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655590
The ClinicalTrials.gov registry entry for NCT00655590 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00655590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00655590 about?
NCT00655590 is a clinical study titled "Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm Function". Assess the effect of daily treatment of vardenafil 20mg or sildenafil 100mg and placebo on sperm function
What is the current status of trial NCT00655590?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2005-01. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00655590?
The interventions under investigation include: Placebo (DRUG), Sildenafil (DRUG), Levitra (Vardenafil, BAY38-9456) (DRUG).
Who is sponsoring clinical trial NCT00655590?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.